Semaglutide for weight loss in people with obesity as an adjunctive treatment for hidradenitis suppurativa: its impact on disease control and quality of life
39 If you can formulate a compounded product that genuinely spares lean mass in a way the branded vials dont, you have a defensible, legal clinical justification to stay in the game
Yes, a face cream can be a supportive tool, but it wont do the heavy lifting on its own.
Current status: Phase 3 trials (expected to continue through 2025-2026) FDA approval timeline: Likely 2026-2027 at the earliest What needs to happen first: Complete Phase 3 trials in larger populations Gather long-term safety data FDA review and approval process Manufacturing scale-up So while the results are exciting, we're still a few years away from retatrutide being available by prescription
Both medications may lead to side effects such as nausea, vomiting, and gastrointestinal upset, which should be discussed with a healthcare provider